Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-297450
Filing Date
2011-11-04
Accepted
2011-11-04 16:27:29
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d234334d10q.htm 10-Q 379597
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) d234334dex311.htm EX-31.1 7897
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) d234334dex312.htm EX-31.2 8015
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO SECTION 906 d234334dex321.htm EX-32.1 4956
  Complete submission text file 0001193125-11-297450.txt   1560920

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT immu-20110930.xml EX-101.INS 173452
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20110930.xsd EX-101.SCH 8558
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immu-20110930_cal.xml EX-101.CAL 33550
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20110930_lab.xml EX-101.LAB 110467
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20110930_pre.xml EX-101.PRE 67427
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 111181454
SIC: 2835 In Vitro & In Vivo Diagnostic Substances